Fidelity Select Biotechnology (FBIOX)
Nasdaq • Currently down 0.19 (-0.61%) in today's trading session
1 member of Congress has disclosed 5 trades in Fidelity Select Biotechnology (FBIOX) via STOCK Act filings. The most recent disclosure was a purchase by Mike Levin on 17 December 2021. Aggregate disclosed activity totals roughly $40K in purchases (midpoint estimates from bracketed disclosure amounts).
Fidelity Select Biotechnology is currently trading at $31.21, positioned at 95% of its 52-week range ($20.49 – $31.72).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
Fidelity Select Biotechnology Price History and Technical Analysis
Congressional Trading Activity for FBIOX
| No data | |||||||
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about FBIOX
- Which members of Congress have traded FBIOX?
- 1 member of Congress has disclosed 5 trade in Fidelity Select Biotechnology (FBIOX) under the STOCK Act: Mike Levin.
- When was FBIOX most recently disclosed by Congress?
- The most recent FBIOX disclosure was a purchase by Mike Levin on 17 December 2021.
- What is the total disclosed congressional trading volume for FBIOX?
- Members of Congress have disclosed approximately $40K in FBIOX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in FBIOX?
- This FBIOX page updates as soon as new STOCK Act disclosures are filed for Fidelity Select Biotechnology. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track FBIOX in Congress
See when politicians buy or sell this stock